Assessment Intravenous Site Events During Outpatient Infusion Procedures With a Wireless Thermal Measurement Device During
Recruiting now · Not applicable
Conditions studied: IV Infiltration, IV Extravasation
In brief
This study evaluates a Non-invasive Thermal Infusion Site Monitor (NTISM) device when used during routine outpatient infusion treatments.
Key facts
- Study ID
- NCT07009405
- Run by
- Rhaeos, Inc.
- People needed
- 10
- Starts
- 2025-05-28
- Expected to finish
- 2025-12-01
- Last updated by the study team
- 2025-06-06
Who can join
Age: 12 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Scheduled to receive an infusion therapy of at least 30 minutes in length
- Region of intact skin proximal to the infusion catheter insertion site that is appropriate in size for application of the study device
- Signed informed consent
- Available for 15 minutes of post-measurement monitoring following removal of the study device
You may not qualify if…
- Patient is under 12 years of age
- Patient-reported history of serious adverse skin reactions to silicone-based adhesives or Tegaderm
- Use of the study device would interfere with standard patient care that cannot be delayed, or participation in the study will interfere with, or be detrimental to, administration of optimal healthcare to the subject
- Investigator judges that the intravenous
Where it is running
- Infusacare — Skokie, Illinois, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.